Black, Hispanic Alzheimer’s patients excluded from new drug testing
New promising treatments for Alzheimer’s disease may not be as beneficial for black and Hispanic sufferers. Leqembi and donanemab, an experimental antibody developed by Eli Lilly, are the first drugs […]
Black, Hispanic Alzheimer’s patients excluded from new drug testing Read More »